Products
Platform
Research
Market
Learn
IPO
Compare UTI Healthcare Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹500 | ₹500 |
Expense Ratio | 2.26 | 1.93 |
NAV | ₹290.29 | ₹433.66 |
Fund Started | 01 Aug 2005 | 04 Jun 1999 |
Fund Size | ₹1124.88 Cr | ₹4082.13 Cr |
Exit Load | Exit load of 1% if redeemed within 30 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
4.0
5.0
Min SIP Amount
₹500
₹500
Expense Ratio
2.26
1.93
NAV
₹290.29
₹433.66
Fund Started
01 Aug 2005
04 Jun 1999
Fund Size
₹1124.88 Cr
₹4082.13 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | 2.78% | 3.38% |
3 Year | 23.94% | 24.80% |
5 Year | 17.64% | 19.54% |
1 Year
2.78%
3.38%
3 Year
23.94%
24.80%
5 Year
17.64%
19.54%
Holding Analysis
Equity | 98.12% | 96.05% |
Cash | 1.87% | 3.88% |
Equity
98.12%
96.05%
Cash
1.87%
3.88%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 9.77% |
Ajanta Pharma Ltd. | 6.25% |
Lupin Ltd. | 5.58% |
Glenmark Pharmaceuticals Ltd. | 4.12% |
Cipla Ltd. | 3.74% |
Procter & Gamble Health Ltd. | 3.67% |
Gland Pharma Ltd. | 3.65% |
Apollo Hospitals Enterprise Ltd. | 3.62% |
Dr. Reddy's Laboratories Ltd. | 3.57% |
Alkem Laboratories Ltd. | 3.52% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.18% |
Divi's Laboratories Ltd. | 7.26% |
Max Healthcare Institute Ltd. | 5.62% |
Cipla Ltd. | 4.41% |
Lonza Group Ag | 4.05% |
Lupin Ltd. | 4.04% |
Acutaas Chemicals Ltd. | 3.81% |
Fortis Healthcare Ltd. | 3.76% |
Torrent Pharmaceuticals Ltd. | 3.49% |
Jupiter Life Line Hospitals Ltd. | 3.46% |
Fund Manager
Name | Kamal Gada | Tanmaya Desai |
Start Date | 02 May 2022 | 17 May 2024 |
Name
Kamal Gada
Tanmaya Desai
Start Date
02 May 2022
17 May 2024
About Fund
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 01 Aug 2005 | 04 Jun 1999 |
Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
01 Aug 2005
04 Jun 1999